CORDIS · 227490 · FP7
EMMASERVICE Servicing the European Biomedical Research Community: Archiving and Dissemination of Mouse Models of Human Disease
Coordinator: CONSIGLIO NAZIONALE DELLE RICERCHE (IT)
The mouse shows great similarities in development, physiology and biochemistry to humans, which makes it a key model for research into human disease. The major challenges for mouse functional genomics in the 21st century are to:1) Develop a series of mutant alleles for every gene in the mouse genome2) Determine the phenotypic consequences of each mutation3) Identify mouse models for the complete disease spectrum in humansTo exploit this emerging resource, mouse models must be preserved and made available to the European biomedical research community. Building on EMMA's previous achievements a…
About Seventh Framework Programme (2007–2013)
The Seventh Framework Programme (FP7) ran from 2007 to 2013 and was the EU's main research-funding instrument of that period. It mobilised roughly €50 billion across cooperation projects, ERC frontier grants, Marie Curie fellowships, capacity-building actions and Euratom research. FP7 closed to new calls in 2013 but its projects continued for years after under their original grant agreements.
EU contribution: €8.0M awarded to the consortium. The project runs over approximately 4 years from 2009-01-01 to 2012-12-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu →More from IT
see all →- THCS — European Partnership on Transforming Health and Care Systems101095654 · HORIZON · €91.6M
- c4c — conect4children (COllaborative Network for European Clinical Trials For Children)777389 · H2020 · €67.0M
- ADITEC — Advanced Immunization Technologies280873 · FP7 · €30.0M
- ARCHETYPE SW550 — Demonstration of innovating parabolic solar trough using an alternative heat transfer fluid producing electricity and fresh water: ARChimede Hot Energy TYPology Enhanced Water Solar 550268181 · FP7 · €29.7M
- EPOS IP — EPOS Implementation Phase676564 · H2020 · €18.4M
- COMETHA — 80,000 TON/Y PRECOMMERCIAL INDUSTRIAL SCALE DEMONSTRATION PLANT ON SECOND GENERATION LIGNOCELLULOSIC ETHANOL322406 · FP7 · €17.9M
Other FP7 projects
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FR · €250.0M
- COMBACTE-NET — Combatting Bacterial Resistance in Europe115523 · SE · €109.4M
- EUC²LID — European Lead Factory115489 · DE · €80.0M
- COMBACTE-MAGNET — Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections115737 · SE · €75.3M
- ENABLE — European Gram Negative Antibacterial Engine115583 · UK · €58.9M
- PLACES2BE — Pilot Lines for Advanced CMOS EmbodimentS in 2x nodes, Built in Europe325633 · FR · €52.6M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Seventh Framework Programme (2007–2013) programme, under the CP-CSA-Infra funding scheme.
- What is the EU contribution?
- The European Commission contributes €8.0M.
- Which EU programme funds it?
- The project is funded under Seventh Framework Programme (2007–2013).
- Who coordinates the project?
- The project is coordinated by CONSIGLIO NAZIONALE DELLE RICERCHE (IT).
- What is the project timeline?
- The project runs from 2009-01-01 to 2012-12-31 — approximately 4 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 227490.